Literature DB >> 31058513

Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer.

Xinli Chen1, Wenxi Zhou1, Chen Liang2,3, Si Shi2,3, Xianjun Yu2,3, Qinjun Chen1, Tao Sun1, Yifei Lu1, Yujie Zhang1, Qin Guo1, Chao Li1, Yu Zhang1, Chen Jiang1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is considered as one of the most aggressive malignancies due to its unique microenvironment of which the cardinal histopathological feature is the remarkable desmoplasia of the stroma, taking up about 80% of the tumor mass. The desmoplastic stroma negatively affects drug diffusion and the infiltration of T cells, leading to an immunosuppressive microenvironment. However, this unique microenvironment can limit the physical spread of pancreatic cancer via a neighbor suppression effect. Here, a tumor central stroma targeting and microenvironment responsive strategy was applied to generate a nanoparticle coloading paclitaxel and phosphorylated gemcitabine. The designed nanoparticle disrupted the central stroma while preserving the external stroma, thereby promoting the antitumor effectiveness of chemotherapeutics. Additionally, the resulting nanoparticle can modulate the tumor immunosuppressive microenvironment by augmenting the number of cytotoxic T cells and restraining the percentage of T regulatory cells. The relatively intact external stroma can effectively maintain the neighbor suppression effect and prevent tumor metastasis. Combining stroma targeting with the delivery of stimuli-responsive polymeric nanoparticles embodies an effective tumor-tailored drug delivery system.

Entities:  

Keywords:  Tumor microenvironment; codelivery; immune therapy; stroma disruption; tumor metastasis

Mesh:

Substances:

Year:  2019        PMID: 31058513     DOI: 10.1021/acs.nanolett.9b00374

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  12 in total

Review 1.  Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.

Authors:  Xi Hu; Fan Xia; Jiyoung Lee; Fangyuan Li; Xiaoyang Lu; Xiaozhen Zhuo; Guangjun Nie; Daishun Ling
Journal:  Adv Sci (Weinh)       Date:  2021-02-12       Impact factor: 16.806

2.  Hydroxy-Propil-β-Cyclodextrin Inclusion Complexes of two Biphenylnicotinamide Derivatives: Formulation and Anti-Proliferative Activity Evaluation in Pancreatic Cancer Cell Models.

Authors:  Rosa Maria Iacobazzi; Annalisa Cutrignelli; Angela Stefanachi; Letizia Porcelli; Angela Assunta Lopedota; Roberta Di Fonte; Antonio Lopalco; Simona Serratì; Valentino Laquintana; Nicola Silvestris; Massimo Franco; Saverio Cellamare; Francesco Leonetti; Amalia Azzariti; Nunzio Denora
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

3.  Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights.

Authors:  Rosa Maria Iacobazzi; Ilaria Arduino; Roberta Di Fonte; Angela Assunta Lopedota; Simona Serratì; Giuseppe Racaniello; Viviana Bruno; Valentino Laquintana; Byung-Chul Lee; Nicola Silvestris; Francesco Leonetti; Nunzio Denora; Letizia Porcelli; Amalia Azzariti
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

4.  Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy.

Authors:  Lei Ding; Ping Zhang; Xu Huang; Kunmeng Yang; Xingkai Liu; Zhenxiang Yu
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 5.  Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.

Authors:  Luman Liu; Prakash G Kshirsagar; Shailendra K Gautam; Mansi Gulati; Emad I Wafa; John C Christiansen; Brianna M White; Surya K Mallapragada; Michael J Wannemuehler; Sushil Kumar; Joyce C Solheim; Surinder K Batra; Aliasger K Salem; Balaji Narasimhan; Maneesh Jain
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 6.  Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.

Authors:  Ming Jia; Dan Zhang; Chunxiang Zhang; Chunhong Li
Journal:  J Nanobiotechnology       Date:  2021-11-22       Impact factor: 10.435

Review 7.  Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.

Authors:  Haijie Han; Su Li; Yueyang Zhong; Yue Huang; Kai Wang; Qiao Jin; Jian Ji; Ke Yao
Journal:  Asian J Pharm Sci       Date:  2021-07-01       Impact factor: 6.598

8.  Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment.

Authors:  Naveed Ullah Khan; Jiang Ni; Xiufeng Ju; Tongtong Miao; Haiyan Chen; Liang Han
Journal:  Acta Pharm Sin B       Date:  2020-10-21       Impact factor: 11.413

9.  A pH-responsive Pickering Nanoemulsion for specified spatial delivery of Immune Checkpoint Inhibitor and Chemotherapy agent to Tumors.

Authors:  Le Jia; Minghui Pang; Man Fan; Xuan Tan; Yiqian Wang; Menglin Huang; Yijing Liu; Qin Wang; Yanhong Zhu; Xiangliang Yang
Journal:  Theranostics       Date:  2020-08-07       Impact factor: 11.556

Review 10.  Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance.

Authors:  Michelle K Greene; Michael C Johnston; Christopher J Scott
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.